These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 632593)

  • 41. Toxoplasma gondii: flat-mounting of retina as a new tool for the observation of ocular infection in mice.
    Escoffier P; Jeanny JC; Marinach-Patrice C; Jonet L; Raoul W; Behar-Cohen F; Paris L; Danis M; Dubremetz JF; Mazier D
    Exp Parasitol; 2010 Oct; 126(2):259-62. PubMed ID: 20412796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Exploration of immune response in a murine model of congenital toxoplasmosis].
    Thouvenin M; Candolfi E; Villard O; Kien T
    Ann Biol Clin (Paris); 1997; 55(5):460-4. PubMed ID: 9347014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.
    Suzuki Y; Wang X; Jortner BS; Payne L; Ni Y; Michie SA; Xu B; Kudo T; Perkins S
    Am J Pathol; 2010 Apr; 176(4):1607-13. PubMed ID: 20167872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.
    Suzuki Y; Orellana MA; Wong SY; Conley FK; Remington JS
    Infect Immun; 1993 Jun; 61(6):2284-8. PubMed ID: 8500870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility to toxoplasmosis: correlation between macrophage function, brain cyst formation and mortality in rats.
    Benedetto N; Folgore A; Ferrara C; Galdiero M
    New Microbiol; 1996 Jan; 19(1):47-58. PubMed ID: 8673852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral Abnormalities in a Mouse Model of Chronic Toxoplasmosis Are Associated with MAG1 Antibody Levels and Cyst Burden.
    Xiao J; Li Y; Prandovszky E; Kannan G; Viscidi RP; Pletnikov MV; Yolken RH
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004674. PubMed ID: 27124472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient nature of Toxoplasma gondii-induced behavioral changes in mice.
    Hrdá S; Votýpka J; Kodym P; Flegr J
    J Parasitol; 2000 Aug; 86(4):657-63. PubMed ID: 10958436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations.
    Goodwin D; Hrubec TC; Klein BG; Strobl JS; Werre SR; Han Q; Zajac AM; Lindsay DS
    J Parasitol; 2012 Aug; 98(4):706-12. PubMed ID: 22468990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunosuppressor effect of Trypanosoma musculi (Mastigophora: Trypanosomatidae) on experimental toxoplasmosis].
    Piccolo-Johanning L; Kellerman-Guterman V; Valerio-Campos I; Chinchilla-Carmona M
    Rev Biol Trop; 2013 Jun; 61(2):981-90. PubMed ID: 23885603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue cyst rupture in mice chronically infected with Toxoplasma gondii. An immunocytochemical and ultrastructural study.
    Ferguson DJ; Hutchison WM; Pettersen E
    Parasitol Res; 1989; 75(8):599-603. PubMed ID: 2771928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. III. Suppression of antibody responses to parasite itself.
    Suzuki Y; Joh K; Kobayashi A
    Cell Immunol; 1987 Dec; 110(2):218-25. PubMed ID: 3690676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections.
    Johnson LL
    Infect Immun; 1992 Sep; 60(9):3719-24. PubMed ID: 1500181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.
    Benmerzouga I; Checkley LA; Ferdig MT; Arrizabalaga G; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6939-45. PubMed ID: 26303803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxoplasma gondii: lymphocyte function during acute infection in mice.
    McLeod R; Van Le L; Remington JS
    Exp Parasitol; 1982 Aug; 54(1):55-63. PubMed ID: 6980139
    [No Abstract]   [Full Text] [Related]  

  • 55. Prooxidant diet provides protection during murine infection with Toxoplasma gondii.
    McCarthy SM; Davis CD
    J Parasitol; 2003 Oct; 89(5):886-94. PubMed ID: 14627133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic Toxoplasma gondii infection contributes to decreasing of perineuronal nets surrounding neurons in the Corpus striatum of mice.
    de Medeiros Brito RM; da Silva Rodrigues Meurer Y; da Silva Santos L; de Melo Marcelino BM; de Andrade-Neto VF
    Parasitol Res; 2020 Jun; 119(6):1989-1995. PubMed ID: 32291469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interrelations of a low-virulence strain of Toxoplasma gondii and inbred mice during late periods of observation].
    Savina MA
    Parazitologiia; 1986; 20(5):413-6. PubMed ID: 3785970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age and sex differences in the response of lymph node post-capillary venules in mice infected with Toxoplasma gondii.
    Henry L; Beverley KA
    Br J Exp Pathol; 1976 Jun; 57(3):274-80. PubMed ID: 952728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression and enhancement of humoral immune response to Toxoplasma gondii by passive antibody.
    Masihi KN; Werner H
    Experientia; 1977 Dec; 33(12):1586-7. PubMed ID: 590445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PD-1 immune checkpoint blockade promotes brain leukocyte infiltration and diminishes cyst burden in a mouse model of Toxoplasma infection.
    Xiao J; Li Y; Yolken RH; Viscidi RP
    J Neuroimmunol; 2018 Jun; 319():55-62. PubMed ID: 29685290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.